US FDA May User Fee Preview: Vaccines, Gene Therapy, And Double Oncologics

 
• By Bridget Silverman

Five novel agents are among the user fee goal dates coming up in May 2024.

RSV test
Moderna's RSV vaccine candidate has a 12 May user fee goal. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers